News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,292 Results
Type
Article (7381)
Company Profile (25)
Press Release (144886)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (53526)
Career Advice (354)
Deals (9456)
Drug Delivery (7)
Drug Development (19903)
Employer Resources (18)
FDA (3716)
Job Trends (3898)
News (84928)
Policy (6535)
Tag
Academia (498)
Accelerated approval (2)
Adcomms (5)
Allergies (33)
Alliances (7415)
ALS (29)
Alzheimer's disease (302)
Antibody-drug conjugate (ADC) (37)
Approvals (3790)
Artificial intelligence (55)
Autoimmune disease (10)
Automation (2)
Bankruptcy (55)
Best Places to Work (3333)
BIOSECURE Act (4)
Biosimilars (36)
Biotechnology (17)
Bladder cancer (31)
Brain cancer (12)
Breast cancer (127)
Cancer (882)
Cardiovascular disease (75)
Career advice (330)
Career pathing (5)
CAR-T (30)
CDC (16)
Cell therapy (90)
Cervical cancer (12)
Clinical research (17350)
Collaboration (181)
Company closure (1)
Compensation (109)
Complete response letters (3)
COVID-19 (620)
CRISPR (10)
C-suite (42)
Cystic fibrosis (18)
Data (1078)
Depression (15)
Diabetes (105)
Diagnostics (1394)
Digital health (5)
Diversity, equity & inclusion (6)
Drug discovery (19)
Drug pricing (15)
Drug shortages (1)
Duchenne muscular dystrophy (44)
Earnings (38962)
Editorial (7)
Employer branding (2)
Employer resources (15)
Events (21400)
Executive appointments (86)
FDA (4232)
Frontotemporal dementia (2)
Funding (151)
Gene editing (25)
Generative AI (5)
Gene therapy (87)
GLP-1 (232)
Government (901)
Grass and pollen (2)
Guidances (149)
Healthcare (4292)
HIV (18)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (53)
Immuno-oncology (4)
Indications (19)
Infectious disease (674)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (28)
Interviews (48)
IPO (5861)
IRA (4)
Job creations (744)
Job search strategy (315)
Kidney cancer (3)
Labor market (17)
Layoffs (126)
Leadership (1)
Legal (1210)
Liver cancer (17)
Longevity (2)
Lung cancer (135)
Lymphoma (68)
Machine learning (1)
Management (7)
Manufacturing (62)
MASH (26)
Medical device (3171)
Medtech (3171)
Mergers & acquisitions (3783)
Metabolic disorders (236)
Multiple sclerosis (27)
NASH (5)
Neurodegenerative disease (21)
Neuropsychiatric disorders (10)
Neuroscience (461)
NextGen: Class of 2025 (1351)
Non-profit (914)
Now hiring (3)
Obesity (111)
Opinion (28)
Ovarian cancer (35)
Pain (25)
Pancreatic cancer (35)
Parkinson's disease (43)
Partnered (5)
Patents (67)
Patient recruitment (31)
Peanut (23)
People (7132)
Pharmaceutical (10)
Pharmacy benefit managers (3)
Phase I (4377)
Phase II (7337)
Phase III (6952)
Pipeline (906)
Policy (31)
Postmarket research (786)
Preclinical (1579)
Press Release (9)
Prostate cancer (55)
Psychedelics (7)
Radiopharmaceuticals (102)
Rare diseases (92)
Real estate (972)
Recruiting (5)
Regulatory (5039)
Reports (18)
Research institute (446)
Resumes & cover letters (40)
Rett syndrome (3)
RNA editing (3)
RSV (24)
Schizophrenia (23)
Series A (22)
Series B (16)
Service/supplier (1)
Sickle cell disease (14)
Special edition (13)
Spinal muscular atrophy (43)
Sponsored (5)
Startups (491)
Stomach cancer (4)
Supply chain (9)
Tariffs (10)
The Weekly (3)
Vaccines (228)
Venture capital (11)
Weight loss (61)
Women's health (9)
Worklife (1)
Date
Today (20)
Last 7 days (85)
Last 30 days (477)
Last 365 days (8886)
2025 (4656)
2024 (9455)
2023 (10669)
2022 (12589)
2021 (13394)
2020 (12173)
2019 (10318)
2018 (7684)
2017 (10866)
2016 (5959)
2015 (7912)
2014 (5565)
2013 (3712)
2012 (4117)
2011 (4301)
2010 (4210)
Location
Africa (269)
Alabama (9)
Alaska (1)
Arizona (29)
Arkansas (2)
Asia (9236)
Australia (1373)
California (1899)
Canada (664)
China (201)
Colorado (100)
Connecticut (75)
Delaware (70)
Europe (23632)
Florida (227)
Georgia (77)
Idaho (9)
Illinois (148)
India (5)
Indiana (112)
Iowa (3)
Japan (63)
Kansas (32)
Kentucky (2)
Louisiana (6)
Maine (30)
Maryland (218)
Massachusetts (1372)
Michigan (63)
Minnesota (111)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (2)
Nevada (36)
New Hampshire (19)
New Jersey (680)
New Mexico (1)
New York (602)
North Carolina (321)
North Dakota (1)
Northern California (886)
Ohio (32)
Oregon (2)
Pennsylvania (444)
Puerto Rico (4)
Rhode Island (1)
South America (360)
South Carolina (4)
Southern California (747)
Tennessee (23)
Texas (256)
United States (7066)
Utah (47)
Virginia (39)
Washington D.C. (11)
Washington State (153)
Wisconsin (17)
152,292 Results for "17".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Announces Dividend - June 17, 2025
June 18, 2025
·
1 min read
Press Releases
LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC
June 27, 2025
·
4 min read
Obesity
Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III
The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application in China and global clinical trials.
July 15, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
June 5, 2025
·
1 min read
Press Releases
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
June 11, 2025
·
1 min read
Press Releases
SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025
June 5, 2025
·
1 min read
Press Releases
Somatic Therapy Market to Reach USD 12.40 Billion by 2032 at 17.5% CAGR: Coherent Market Insights
July 1, 2025
·
1 min read
Press Releases
GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034
July 14, 2025
·
1 min read
Press Releases
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program
June 25, 2025
·
4 min read
Press Releases
Humira Market Size Hit USD 1.20 Billion by 2032, Growing at a CAGR of -17.6% from 2024 to 2032
July 2, 2025
·
1 min read
1 of 15,230
Next
